ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

ClinicalTrials.gov ID: NCT05090371

Public ClinicalTrials.gov record NCT05090371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light Levels (SOSTOS)

Study identification

NCT ID
NCT05090371
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

  • Disease modifying treatment (DMT) Drug
  • Ofatumumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2022
Primary completion
Apr 12, 2027
Completion
Apr 12, 2027
Last update posted
Mar 29, 2026

2022 – 2027

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Alabama Neurology Associates PC Birmingham Alabama 35209
North Central Neurology Associates PC Cullman Alabama 35058
Radiant Research Chandler Chandler Arizona 85224
Arizona Neuroscience Research LLC Phoenix Arizona 85032
University of California at Los Angeles Torrance California 90509-2004
Neurology of Central FL Res Ctr Altamonte Springs Florida 32714
S And D Clinical Research Cape Coral Florida 33904
Homestead Assoc In Research Inc Homestead Florida 33033
Neurology Associates PA Maitland Florida 32751
Orlando Health Clinical Trials Orlando Florida 32806
Emerald Coast Neurology Pensacola Florida 32514
University Of South Florida Tampa Florida 33612
Kootenai Health Coeur d'Alene Idaho 83815
Neuro Medial Clinic of Central Louisiana Alexandria Louisiana 71301
International Neurorehab Institute Lutherville Maryland 21093
Reliant Medical Group Worcester Massachusetts 01608
Henry Ford Hospital Detroit Michigan 48202-2689
Memorial Healthcare Owosso Michigan 48867
University of Mississippi Medical Center Jackson Mississippi 39216-4505
St Barnabas Medical Center Livingston New Jersey 07039
Jersey Shore University Medical Ctr Neptune City New Jersey 07753
SUNY Upstate Medical Center Syracuse New York 13210
University Of NC At Chapel Hill Chapel Hill North Carolina 27599 9500
Piedmont HealthCare Charlotte North Carolina 28210
Velocity Clinical Research Raleigh North Carolina 27607
Palmetto Clinical Research Summerville South Carolina 29485
Sibyl Wray MD Neurology PC Knoxville Tennessee 37922
Clinical Trial Network Houston Texas 77074
Neuro Mind Clinical Trials Ltd Co Katy Texas 77449
Covenant Medical Group Lubbock Texas 79410
West Texas Cancer Center Odessa Texas 79761
Tranquil Clinical Research Webster Texas 77598
Sentara Neuroscience Institute Virginia Beach Virginia 23456
Evergreen Health Multiple Sclerosis Center Kirkland Washington 98034
Swedish Medical Center Seattle Washington 98122-4379
Aurora BayCare Medical Center Green Bay Wisconsin 54311
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05090371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05090371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →